BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2004
View Archived Issues
Gabapentin delays ejaculation in a case of PE / News in Context
Read More
New angiotensin II receptor agonists covered by Vicore patent
Read More
New GLP-2 derivatives and their use in gastrointestinal disorders
Read More
GSK researchers identify new ROCK inhibitors for use in cardiovascular and other disorders
Read More
Merck claims prostaglandin analogues as EP4 receptor agonists for ocular and bone conditions
Read More
Emory University patents CXCR4 antagonists and their use in cancer
Read More
Novel method for treatment for neutrophil-mediated conditions
Read More
Pharmacokinetic interactions with UK-427857 studied
Read More
Selective TRPV1 receptor antagonist shows analgesic effect in vivo
Read More
CAT and AstraZeneca form alliance in inflammatory disorders
Read More
Nonendocannabinoid inhibitor of anadamide inactivation shows analgesic effects in pain model
Read More
Alfacell and NCI pursue development of RN-321
Read More
Novel 1beta-methylcarbapanem shows promising antibacterial activity
Read More
Vesicare approved by FDA
Read More
Poor bioavailability results for R-803 in phase I/II HCV study
Read More
Multitarget antimalarial vaccine effective in non-human primates
Read More
BEYOND study of Betaferon recommended to continue
Read More
NDA submission for indiplon modified release
Read More
New Roche study investigates response rates to HCV therapy in Latinos
Read More
Synta closes financing round
Read More
Bayer signs development agreement for longer-acting Kogenate
Read More
EHT-0202 to enter phase IIa proof-of-concept study in Alzheimer's in 2005
Read More
European approval for Bayer's acquisition of Roche consumer health business
Read More
TMC-114 active against resistant HIV-1
Read More
Long-term antiviral activity of TMC-125 seen in HIV-infected patients
Read More
Liarozole reported safe and effective in the treatment of ichthyosis and psoriasis
Read More
Cilansetron improves quality of life of patients with diarrhea-predominant IBS
Read More
Study of interferon gamma-1b in idiopathic pulmonary fibrosis continues
Read More
Clinical data confirm the benefits of AGI-1067 in atherosclerosis
Read More
Phase II data on the therapeutic benefits of dexanabinol in CABG-associated cognitive impairment
Read More
Results of phase I study of FG-3019 in idiopathic pulmonary fibrosis
Read More